LBT Innovations Limited (LBT.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -4.04 Million AUD | 76.35% |
| 2023 | -17.11 Million AUD | 22.62% |
| 2022 | -5.17 Million AUD | -30.56% |
| 2021 | -6.61 Million AUD | -14.05% |
| 2020 | -3.33 Million AUD | 35.53% |
| 2019 | -3.82 Million AUD | 35.11% |
| 2018 | -3.22 Million AUD | 1.35% |
| 2017 | -8.08 Million AUD | -281.63% |
| 2016 | 5.16 Million AUD | 3028.95% |
| 2015 | -152 Thousand AUD | 82.2% |
| 2014 | -854 Thousand AUD | -185.66% |
| 2013 | 997 Thousand AUD | 182.33% |
| 2012 | -1.21 Million AUD | 36.76% |
| 2011 | -1.91 Million AUD | -199.74% |
| 2010 | 1.92 Million AUD | 2460.0% |
| 2009 | 75 Thousand AUD | -70.82% |
| 2008 | 257 Thousand AUD | -84.54% |
| 2007 | 1.18 Million AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | -2.57 Million AUD | 0.0% |
| 2024 FY | - AUD | -17.09% |
| 2024 Q2 | -1.77 Million AUD | 0.0% |
| 2023 Q2 | -2.33 Million AUD | 0.0% |
| 2023 Q4 | -1.28 Million AUD | 0.0% |
| 2023 FY | - AUD | 22.62% |
| 2022 FY | - AUD | -30.56% |
| 2022 Q4 | -2.6 Million AUD | 0.0% |
| 2022 Q2 | -2.03 Million AUD | 0.0% |
| 2021 Q4 | -2.01 Million AUD | 0.0% |
| 2021 FY | - AUD | -14.05% |
| 2021 Q2 | -1.79 Million AUD | 0.0% |
| 2020 Q2 | -1.78 Million AUD | 0.0% |
| 2020 Q4 | -1.55 Million AUD | 0.0% |
| 2020 FY | - AUD | 35.53% |
| 2019 FY | - AUD | 35.11% |
| 2019 Q4 | -254 Thousand AUD | 0.0% |
| 2019 Q2 | -1.55 Million AUD | 0.0% |
| 2018 FY | - AUD | 1.35% |
| 2018 Q4 | -1.75 Million AUD | 0.0% |
| 2018 Q2 | -1.71 Million AUD | 0.0% |
| 2017 Q2 | -407 Thousand AUD | 0.0% |
| 2017 Q4 | -10.62 Million AUD | 0.0% |
| 2017 FY | - AUD | -281.63% |
| 2016 Q2 | 4.08 Million AUD | 0.0% |
| 2016 Q4 | 363 Thousand AUD | 0.0% |
| 2016 FY | - AUD | 3028.95% |
| 2015 Q4 | -838 Thousand AUD | 0.0% |
| 2015 FY | - AUD | 82.2% |
| 2015 Q2 | 686 Thousand AUD | 0.0% |
| 2014 FY | - AUD | -185.66% |
| 2014 Q2 | 377 Thousand AUD | 0.0% |
| 2014 Q4 | -1.23 Million AUD | 0.0% |
| 2013 Q2 | -1.12 Million AUD | 0.0% |
| 2013 FY | - AUD | 182.33% |
| 2013 Q4 | 1.53 Million AUD | 0.0% |
| 2012 Q2 | -258.5 Thousand AUD | 38.27% |
| 2012 Q3 | -258.5 Thousand AUD | 0.0% |
| 2012 Q4 | -258.5 Thousand AUD | 0.0% |
| 2012 FY | - AUD | 36.76% |
| 2012 Q1 | -418.75 Thousand AUD | 0.0% |
| 2011 FY | - AUD | -199.74% |
| 2011 Q2 | -418.75 Thousand AUD | -181.51% |
| 2011 Q1 | 513.75 Thousand AUD | 0.0% |
| 2011 Q3 | -418.75 Thousand AUD | 0.0% |
| 2011 Q4 | -418.75 Thousand AUD | 0.0% |
| 2010 Q2 | 513.75 Thousand AUD | 582.72% |
| 2010 FY | - AUD | 2460.0% |
| 2010 Q1 | 75.25 Thousand AUD | 0.0% |
| 2010 Q4 | 513.75 Thousand AUD | 0.0% |
| 2010 Q3 | 513.75 Thousand AUD | 0.0% |
| 2009 Q4 | 75.25 Thousand AUD | 0.0% |
| 2009 Q3 | 75.25 Thousand AUD | 0.0% |
| 2009 Q1 | 64.25 Thousand AUD | 0.0% |
| 2009 Q2 | 75.25 Thousand AUD | 17.12% |
| 2009 FY | - AUD | -70.82% |
| 2008 Q2 | 64.25 Thousand AUD | -78.23% |
| 2008 Q3 | 64.25 Thousand AUD | 0.0% |
| 2008 FY | - AUD | -84.54% |
| 2008 Q4 | 64.25 Thousand AUD | 0.0% |
| 2008 Q1 | 295.13 Thousand AUD | 0.0% |
| 2007 Q3 | 295.13 Thousand AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2007 Q2 | 295.13 Thousand AUD | 0.0% |
| 2007 Q4 | 295.13 Thousand AUD | 0.0% |
| 2006 Q1 | - AUD | 0.0% |
| 2005 Q3 | - AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q2 | - AUD | 0.0% |
| 2005 Q4 | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 88.774% |
| Adherium Limited | -11.56 Million AUD | 64.988% |
| Aroa Biosurgery Limited | -7.36 Million AUD | 44.987% |
| Atomo Diagnostics Limited | -5.42 Million AUD | 25.343% |
| Anteris Technologies Ltd | -66.9 Million AUD | 93.948% |
| Control Bionics Limited | -5.15 Million AUD | 21.504% |
| CardieX Limited | -6.71 Million AUD | 39.674% |
| Compumedics Limited | 2.78 Million AUD | 245.177% |
| Cochlear Limited | 579.5 Million AUD | 100.699% |
| CleanSpace Holdings Limited | -3.49 Million AUD | -15.957% |
| Cyclopharm Limited | -3.03 Million AUD | -33.415% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | -93.62% |
| Nova Eye Medical Limited | -5.97 Million AUD | 32.28% |
| HeraMED Limited | -3.97 Million AUD | -1.937% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | 81.486% |
| ImpediMed Limited | -22.05 Million AUD | 81.638% |
| InhaleRx Limited | -1.41 Million AUD | -186.403% |
| Micro-X Limited | -14.35 Million AUD | 71.786% |
| Neurotech International Limited | -8.24 Million AUD | 50.886% |
| OncoSil Medical Limited | -11.97 Million AUD | 66.191% |
| PolyNovo Limited | 5.17 Million AUD | 178.317% |
| Respiri Limited | -7.04 Million AUD | 42.567% |
| SomnoMed Limited | -2.32 Million AUD | -73.88% |
| Universal Biosensors, Inc. | -9.09 Million AUD | 55.459% |
| Uscom Limited | -1.5 Million AUD | -168.268% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | 17.66% |